Interferon Enhances the Fragility of Lysosomes in L-929
Mouse Fibroblasts (Accepted 8 December 1977) SUMMARY Infection of interferon-treated L-929 mouse fibroblasts with vaccinia WR virus is followed by severe cytolysis within 3 to 4 h. It is shown that this cytolysis cannot be caused by enzymes released from lysosomes into the cytosol. However, there is evidence that homologous interferon has a noxious effect on lysosomes. This phenomenon appears to be another aspect of the anticellular functions of interferon.
Treatment of animal cells with homologous interferon prior to virus infection is in many systems followed by the development of a more or less marked antiviral status, characterized by an inhibition of virus replication and a considerable protection of the infected cells (Isaacs & Lindenmann, I957 ) . Besides this classical interferon action, various studies, especially on murine systems, have revealed certain biological effects of interferon preparations which are directed against the cell itself (Gresser et al. 197o, 1971; Knight, T976) . Attempts have been made to separate a hypothetical anticellular activity from a fraction with antiviral activity (Stewart et al. 197I, I973; Dahl & Degre, I975) , but genetic and recent biochemical data suggest that both activities are associated with the same protein component in the interferon preparations (Knight, ~976; Tan, I976) .
In some virus-cell systems interferon treatment has a somewhat paradoxical effect: even though virus multiplication is inhibited, the infected cells are not protected against virus cytopathic effects (c.p.e.). In special cases, cell death occurs even more rapidly after interferon treatment than in infected cells not treated with interferon. For example, 3 to 4 h after infection with vaccinia WR virus, interferon-treated L-9z9 cells show severe cytolysis and, with increasing time of infection, completely disintegrate. Control cells not treated with interferon exhibit the characteristic vaccinia-specific c.p.e, but cytolysis is not observed (Joklik & Merigan, ~966) . It has been demonstrated that both mouse interferon and virus functions are jointly responsible for this phenomenon (Horak et al. 1970 .
It has been suggested previously that the release of enzymes from lysosomes into the free cytosol is a pathogenetic event in the development of virus c.p.e. (Defendi, 1962; Allison & Sandelin, I963 ; DeDuve, I963). We therefore investigated the possible involvement of lysosomes in the lytic process occurring in L-929 cells treated with homologous interferon before infection with vaccinia WR virus.
L-929 cells grown in Roux flasks to a density of about 5 x Io 7 cells in Eagle's minimum essential medium (MEM) and IO ~ calf serum were pre-treated with chicken or mouse interferon overnight at a concentration of 500 to tooo units/ml. The propagation and purification of vaccinia WR virus, and the preparation of mouse interferon (sp. act. : 7ooooo units/mg protein) and chick interferon (sp. act. : 8ooooo units/rag protein) was performed as previously described (Jungwirth et al. I972) . Mouse interferon activity was determined by a plaque reduction assay using vesicular stomatitis virus. One unit corresponds to 15 units of the National Institute of Health (Bethesda, U.S.A.) reference standard. For infection with vaccinia WR virus, the growth medium was removed, and the cells were Short communications washed twice with fresh medium and infected with vaccinia WR virus at a multiplicity of rooo elementary bodies/cell (corresponding to 2o infectious particles/cell). After virus adsorption for I h at 37 °C, the conditioned interferon medium was returned to the cultures. At various times after infection cells were harvested by treatment with o'5 ~ trypsin solution for 5 min, washed twice with cold phosphate buffered saline (PBS), suspended in o-Iz5 Msucrose/PBS and disrupted in a Dounce homogenizer (Braun, Melsungen), with 2o strokes of a tight fitting pestle. The homogenate was centrifuged at zoooo g for zo rain at 4 °C. (Guskey et al. I97O) . At various times, the distribution of lysosomal enzyme activities between these cellular compartments was related to the development of cytolysis, which was simultaneously measured in terms of the release of intracellular 51chromium into the culture medium (Wigzell, I965). The experimental conditions were the same except that the cells were labelled with 51Cr-NaCrO4 (sp. act. 2o0 mCi/mg, Amersham) for 30 min immediately before infection. At various times after infection, samples of medium were aspirated from the cell cultures and clarified by centrifugation at 2ooo g for 5 min. The radioactivity released from the cells was determined by directly counting o.~ ml samples of the cell-free medium in Bray scintillation liquid (the/?-part of the total 51Cr radiation was measured).
As shown in Fig. I (a) and (b), treatment of L-929 cells with homologous interferon alone was followed by a significant release of the lysosomal hydrolase/]-galactosidase into the cytosol. The same results were achieved when fl-glucuronidase and acid DNase activities were tested (data not shown). Infection of cells with vaccinia WR virus, which led to the development of typical vaccinia-virus-specific c.p.e, within 3 h, was not accompanied by a release of lysosomal enzymes into the cytosol. Also, cell-bound S~Cr label was not released into the medium. After treatment with homologous interferon, infection of L cells was followed by rapid cytolysis monitored by a sharp rise of free S~Cr in the medium. The level of free acid hydrolases in the cytosol of interferon-treated and vaccinia-infected L cells, however, was -even when cells were just about to disintegrate -not higher than in uninfected interferon-treated cells, which remained morphologically unchanged. The alteration of the distribution of lysosomal enzyme activity could not be induced by heterologous chicken interferon or by heat-inactivated mouse interferon (data not shown).
From these findings two conclusions can be drawn. First, pre-treatment of mouse L-929 cells with homologous interferon alone renders the lysosomes more fragile, so that either intracellularly or during preparation of the cellular fractions, specific lysosomal hydrolases are released into the cytosol fraction to a significantly higher extent than in cells not treated with interferon. This activity appears to be another manifestation of the anticellular activities of mouse interferon preparations. Second, since the normal distribution pattern of lysosomal enzymes between the two cellular fractions is not altered by infection of L-929 cells 
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